Synergistic nanomedicine overcomes hypoxia-driven DNA repair to potentiate radiotherapy for lung adenocarcinoma
Theranostics · 2026
DOI: 10.7150/thno.132916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Zhichang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Precision Therapeutics, Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidi…. Hauptthemen laut MEDLINE: DNA Repair, Adenocarcinoma of Lung, Lung Neoplasms, Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Precision Therapeutics, Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institution of Radiology and Medical Imaging, Huaxi MR Research Ce…
- Frontier Medical Center, Tianfu Jincheng Laboratory, Chengdu, 610041, China.
- Psychoradiology Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
Zitieren
APA
Liu, Z., Qiu, Y., Chen, J., Li, J., Zhuang, C., Feng, Q., Huang, J., Xiao, C., Zheng, X., Luo, K., & Xiao, K. (2026). Synergistic nanomedicine overcomes hypoxia-driven DNA repair to potentiate radiotherapy for lung adenocarcinoma. Theranostics. https://doi.org/10.7150/thno.132916
Vancouver
Liu Z, Qiu Y, Chen J, Li J, Zhuang C, Feng Q, et al. Synergistic nanomedicine overcomes hypoxia-driven DNA repair to potentiate radiotherapy for lung adenocarcinoma. Theranostics. 2026. doi:10.7150/thno.132916
BibTeX
@article{Liu2026,
author = {Liu, Zhichang and Qiu, Yue and Chen, Jie and Li, Jue and Zhuang, Cheng and Feng, Qiyi and Huang, Jinxing and Xiao, Chunxiu and Zheng, Xiuli and Luo, Kui and Xiao, Kai},
title = {Synergistic nanomedicine overcomes hypoxia-driven DNA repair to potentiate radiotherapy for lung adenocarcinoma},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.132916}
}
EUVIMED